Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
BMJ (Clinical Research Ed.)
|
February 8, 2019
Primary cervical screening with high risk human papillomavirus testing: observational study
Matejka Rebolj, Janet Rimmer, Karin Denton, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma
Dennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
The European Respiratory Journal
|
March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S Harvey, David Langton, Constance Katelaris, et al.
International Journal of Environmental Research and Public Health
|
June 24, 2022
'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma
Tesfalidet Beyene, Erin S Harvey, Joseph Van Buskirk, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 17, 2023
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity
Anne E Vertigan, Erin S Harvey, Tesfalidet Beyene, et al.
Allergy
|
August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Dennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry
Dennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Respirology (Carlton, Vic.)
|
September 20, 2018
Treatable traits can be identified in a severe asthma registry and predict future exacerbations
Vanessa M McDonald, Sarah A Hiles, Krystelle Godbout, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
BMJ (Clinical Research Ed.)
|
February 8, 2019
Primary cervical screening with high risk human papillomavirus testing: observational study
Matejka Rebolj, Janet Rimmer, Karin Denton, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma
Dennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
The European Respiratory Journal
|
March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S Harvey, David Langton, Constance Katelaris, et al.
International Journal of Environmental Research and Public Health
|
June 24, 2022
'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma
Tesfalidet Beyene, Erin S Harvey, Joseph Van Buskirk, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 17, 2023
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity
Anne E Vertigan, Erin S Harvey, Tesfalidet Beyene, et al.
Allergy
|
August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Dennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry
Dennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Respirology (Carlton, Vic.)
|
September 20, 2018
Treatable traits can be identified in a severe asthma registry and predict future exacerbations
Vanessa M McDonald, Sarah A Hiles, Krystelle Godbout, et al.
Page
of 6